Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationMatthias Gückenberger, Piet Ost, Yolande Lievens et al.|The Lancet Oncology|2020Cited by 1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentYolande Lievens, Wendy A. Woodward, David A. Palma et al.|Radiotherapy and Oncology|2020Cited by 646
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementMatthias Gückenberger, David A. Palma, Claus Belka et al.|Radiotherapy and Oncology|2020Cited by 227
European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology CommissionMark Lawler, Richard Sullivan, Lynne Davies et al.|The Lancet Oncology|2022Cited by 104